A Study of the Effect of SYN-010 on Subjects With IBS-C

Clinical trial NCT02495623 · COMPLETED

Trial details

NCT number: NCT02495623
Sponsor: Theriva Biologics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome With Constipation (IBS-C)

Start date: 2015-06-01
Primary completion: 2015-10-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.